Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects with an IPAA (PROF)
- First Posted Date
- 2023-07-10
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Exegi Pharma, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT05938465
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Mayo Clinic - Florida (Inflammatory Bowel Disease Center), Jacksonville, Florida, United States
🇺🇸Corewell Health, Grand Rapids, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath